On-X® Life Technologies Inc. has announced that it will officially launch its On-X Plus 1.5 Aortic Heart Valve at the Annual Meeting & Cardiothoracic Forum of the Society for Cardiothoracic Surgery in Great Britain & Ireland, March 10-12, Edinburgh, Scotland.
Long term clinical outcomes, presented at last month's Cardiovascular Research Technologies Conference suggest that Micell has found an optimal combination of rapid absorbable polymer, coupled with anti-restenotic drug, yielding impressive results at 18 months.
Heart assist device company Thoratec Corporation has initiated a voluntary worldwide Medical Device Correction in order to update its labeling and training materials for the HeartMate II® LVAS Pocket System Controller. The advisory follows four deaths among patients while initiating switches of controller.
Artificial muscle is so much harder to develop than any number of joints or even organs like heart valves. After all, muscles need to be active rather than passive participants in making bodily things happen. A U.S. research team has published its efforts in this month's Science journal and they sound promising.
Reuters has reported the death of the first patient fitted with an artificial heart made by the French company Carmat following implantation of the device in December. Sad as the news is, the device has actually achieved its primary efficacy outcome by surviving over a month post-transplant.
Cook Medical has updated us with news that the first ten patients in its VIVO venous stent study have been treated with the Zilver Vena stent.
Whatever PR fluff is attached to them, the numbers you see in financial press releases are mostly capable of withstanding forensic scrutiny. For that reason we're falling back in love with them, despite their rather anodyne nature.
One year data in the European multicenter clinical study into use of the VenaSeal Sapheon Closure System has yielded results that suggest it works and didn't require recanalization in a single patient.
Whether this is a milestone or not remains to be seen, but it just might be. The PEEK polymer has become a household name in orthopaedic implants and now MedShape is offering devices with the combined advantages of PEEK and a porous structure to encourage tissue ingrowth.
An implantable drug delivery pump forms the basis of a new company, Medallion Therapeutics, Inc., which has sprung from the Alfred Mann Foundation (AMF) for Scientific Research.
Frequent visitor to our pages, cardiovascular device company Biotronik has announced the first implantations of the Sentus ProMRI® lead.
Eucomed's Chief Executive, Serge Bernasconi is making sure medtech industry's voice is being heard right until the last minute as final wording is being inked into the new medical device directives. Highlights from his newly issued blog included here.
InTone® MV is a clever device which combines muscle stimulation with voice-guided pelvic floor exercise, visual biofeedback, and a unique, customizable probe to create a home-based treatment for fecal and urinary incontinence in men and women.
New entrant into the orthopaedic device space, EDGE Orthopaedics has its first FDA 510(k) Clearance in the form of a range of compression screws.
Atrial Fibrillation device specialist AtriCure, Inc. has announced fourth quarter and full year 2013 financial results showing 16 percent revenue growth for the year. It also looks like the Estech acquisition is working out nicely.